Grace Therapeutics, Inc.
GRCE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444192
In the last 90 days, Grace Therapeutics, Inc. insiders filed 5 open-market purchases and 0 sales; 33 institutions reported holding it in 13F filings for Q2 2026, worth $8.74M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Grace Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| SharesConverted for a 1-for-6 split | 64.9K | 558.3K | +493.4K (+760.0%) |
| Value | $204.2K | $1.55M | +$1.35M (+660.3%) |
New holders (6)
Institutions that held Grace Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 494,698 | $1.38M | 0.00% |
| Coastal Bridge Advisors, LLC | 10,000 | $27.8K | 0.01% |
| UBS Group AG | 4,712 | $13.1K | 0.00% |
| JPMorgan Chase & Co | 3,358 | $9.20K | 0.00% |
| Impact Partnership Wealth, LLC | 10 | $28 | 0.00% |
| NBC Securities, Inc. | 2 | $0 | 0.00% |
Sold out (5)
Institutions that held Grace Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Renaissance Technologies LLC | 67,600 | $35.0K |
| Geode Capital Management, LLC | 18,348 | $9.63K |
| Two Sigma Securities, LLC | 15,087 | $7.92K |
| Jane Street Group, LLC | 14,216 | $7.46K |
| ICA Group Wealth Management, LLC | 57 | $29 |